ARTICLE | Company News
Life Science in-licenses Kyowa's KW-2871
March 16, 2007 1:21 AM UTC
Kyowa Hakko Kogyo (Tokyo:4151) granted Life Science Pharmaceuticals (Greenwich, Conn.) exclusive worldwide rights to develop and market KW-2871 to treat malignant melanoma. Life Science plans to start...